HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Prostate Cancer

Prostate Cancer

Prostate cancer remains a significant focus in cancer research due to its prevalence and impact on men's health. Studies delve into various aspects, from understanding its molecular mechanisms to refining diagnostic techniques and treatment options. Researchers explore genetic factors influencing prostate cancer risk and progression, paving the way for personalized medicine approaches. Advanced imaging technologies aid in early detection and monitoring, crucial for improving survival rates. Additionally, immunotherapy and targeted therapies show promise in enhancing treatment efficacy with fewer side effects. Collaborative efforts between scientists, clinicians, and patients drive progress in prostate cancer research, aiming for better outcomes and quality of life for affected individuals. As research continues to evolve, the future holds prospects for more effective prevention, detection, and treatment strategies in combating this prevalent disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp